Obstetrics & Gynecology Doctors in Chappaqua, NY Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Dr. Brad Shumel, M.D. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6 Brittany Ct, Chappaqua, NY 10514 Phone: 914-239-4919

Anna Romanova, MD Obstetrics & Gynecology - Female Pelvic Medicine and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 480 Bedford Rd, Chappaqua, NY 10514 Phone: 914-223-1747    Fax: 914-223-1718

Dr. Corinne December Menn, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 16 S Bedford Rd, Suite 3e, Chappaqua, NY 10514 Phone: 914-238-0350

Tracy Shevell, MD Obstetrics & Gynecology - Gynecology Medicare: Medicare Enrolled Practice Location: 480 Bedford Rd, Chappaqua, NY 10514 Phone: 203-276-7060

News Archive

EC approves expanded use of Daklinza (daclatasvir) for patients with chronic HCV and HIV co-infection

Bristol-Myers Squibb today announced that the European Commission has approved the expanded use of Daklinza, a first-in-class oral, once-a-day pill used in combination with other treatments as an option for adult patients with chronic hepatitis C virus infection who are co-infected with HIV or who have had a prior liver transplant.

PCMA releases statement on GAO report that examines specialty-tier prescription drugs in Medicare Part D

"Meaningful biogenerics legislation should be the first stop for policymakers tasked with financing health reform. PCMA and a broad coalition of consumers, employers, labor unions, and others support bipartisan legislation that would create a regulatory pathway for the Food and Drug Administration to approve generic versions of biologic products."

CPCM to facilitate acquisitions training under contract with NGA

Ms. Dell Bowman, Certified Professional Contracts Manager, in affiliation with The Ravens Group will be facilitating acquisitions training under a contract with the National Geospatial Intelligence Agency. This best-in-class Performance Based Service Acquisition training will take place in Washington, DC and St. Louis, Missouri.

AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance program

Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.

Read more Medical News

› Verified 7 days ago